These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5818071)

  • 1. Survey of cytological facilities in Canada.
    Anderson GH; Thompson DW; Kulcsar DD
    Can Med Assoc J; 1969 Sep; 101(5):279-85. PubMed ID: 5818071
    [No Abstract]   [Full Text] [Related]  

  • 2. Survey of cytological facilities in Canada.
    Kulcsar DD
    Can Med Assoc J; 1966 Jun; 94(23):1228-34. PubMed ID: 5939557
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical cytology in gynecologic problems].
    Johannisson E
    Lakartidningen; 1969 Nov; 66(45):4659-67. PubMed ID: 5405936
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of screening programmes on laboratory organization.
    Signy AG
    Proc R Soc Med; 1971 Dec; 64(12):1261-2. PubMed ID: 5167165
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of longterm hospital based cytological screening in asymptomatic women.
    Misra JS; Singh U
    Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [10-year cytodiagnosis of cervical carcinoma: results and further developments].
    Wagner D
    Geburtshilfe Frauenheilkd; 1966 Aug; 26(8):1135-44. PubMed ID: 5990257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mass screening for women].
    Selander K
    Katilolehti; 1973 Apr; 78(4):182-7. PubMed ID: 4487796
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comparison of colcoscopic and cytological methods applied in Tampere's mass screening program, 1965-69].
    Kauppila O; Lauslahti K; Rissanen P
    Duodecim; 1971; 87(1):45-51. PubMed ID: 5539582
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytodiagnosis of HSV-2 infection of the female genitalia in obstetrical, gynecological and oncological practice].
    Tsanev K; Manolova Ia
    Akush Ginekol (Sofiia); 1983; 22(3):207-10. PubMed ID: 6686415
    [No Abstract]   [Full Text] [Related]  

  • 10. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 11. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Walton report on cervical cancer screening programs in Canada.
    Kassirer E
    Can Med Assoc J; 1980 Feb; 122(4):417-23. PubMed ID: 7370844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for improving gynecologic cytology screening.
    Renshaw AA
    Cancer; 2009 Jun; 117(3):151-3. PubMed ID: 19618478
    [No Abstract]   [Full Text] [Related]  

  • 14. [MASS CYTOLOGICAL TESTS IN CANADA AND THE USA].
    CLEMMESEN J
    Ugeskr Laeger; 1964 Jan; 126():82-4. PubMed ID: 14115394
    [No Abstract]   [Full Text] [Related]  

  • 15. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study.
    Wikström I; Stenvall H; Wilander E
    Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethnic distribution of cytologically diagnosed herpes simplex genital infections in a cervical cancer screening program.
    Jordan SW; Evangel E; Smith NL
    Acta Cytol; 1972; 16(4):363-5. PubMed ID: 4338534
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for cervical cancer. Canadian programmatic guidelines.
    Parboosingh J
    Can Fam Physician; 1999 Feb; 45():383-93. PubMed ID: 10065312
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of genital infection on cervical cytology.
    Hicks DA
    Sex Transm Infect; 1998 Dec; 74(6):457; discussion 458. PubMed ID: 10195064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of cytodiagnosis of cervix cancer during prophylactic examinations].
    Gladysheva VA; Chernova VD; Ivanova AV
    Lab Delo; 1982; (9):519-21. PubMed ID: 6183511
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversy brews over cervical cancer screening.
    Healthc Demand Dis Manag; 1998 Feb; 4(2):17-21. PubMed ID: 10178013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.